Luca Murru

Luca Murru

Auto-generated profile, based on publicly available information

Luca Murru

Institute of Neuroscience, CNR

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
EMEdoardo Moretto
Edoardo Moretto
LMLuca Murru
Luca Murru
Giuseppe MartanoGiuseppe Martano
Giuseppe Martano
JSJenny Sassone
Jenny Sassone
MPMaria Passafaro
Maria Passafaro

27 May 2014 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
MCMaria D. Cirnaru
Maria D. Cirnaru
AMAntonella Marte
Antonella Marte
Elisa BelluzziElisa Belluzzi
Elisa Belluzzi
IRIsabella Russo
Isabella Russo
Martina GabrielliMartina Gabrielli
Martina Gabrielli
GPGiovanni Piccoli
Giovanni Piccoli
Mutations in Leucine-rich repeat kinase 2 gene (LRRK2) are associated with familial and sporadic Parkinson’s disease (PD). LRRK2 is a complex protein that consists of multiple domains executing several functions, including GTP hydrolysis, kinase activity and protein binding. Robust evidence suggests that LRRK2 acts at the synaptic site as a molecular hub connecting synaptic vesicles to cytoskeletal elements via a complex panel of protein-protein interactions. Here we investigated the impact of pharmacological inhibition of LRRK2 kinase activity on synaptic function. Acute treatment with LRRK2 inhibitors reduced the frequency of spontaneous currents, the rate of synaptic vesicle trafficking and the release of neurotransmitter from isolated synaptosomes. The investigation of complementary models lacking LRRK2 expression allowed us to exclude potential off-side effects of kinase inhibitors on synaptic functions. Next we studied whether kinase inhibition affects LRRK2 heterologous interactions. We found that the binding among LRRK2, presynaptic proteins and synaptic vesicles is affected by kinase inhibition. Our results suggest that LRRK2 kinase activity influences synaptic vesicle release via modulation of LRRK2 macro-molecular complex.

4 October 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Nunzio DenoraNunzio Denora
Nunzio Denora
VLValentino Laquintana
Valentino Laquintana
MPMaria Giuseppina Pisu
Maria Giuseppina Pisu
RDRiccardo Dore
Riccardo Dore
LMLuca Murru
Luca Murru
ESEnrico Sanna
Enrico Sanna

11 February 2009 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ESEnrico Sanna
Enrico Sanna
MMMaria Cristina Mostallino
Maria Cristina Mostallino
LMLuca Murru
Luca Murru
MCMario Carta
Mario Carta
GTGiuseppe Talani
Giuseppe Talani
GBGiovanni Biggio
Giovanni Biggio
Pregnancy is associated with changes in mood and anxiety level as well as with marked hormonal fluctuations. Increases in the brain concentrations of neuroactive steroids during pregnancy in rats are accompanied by changes in expression of subunits of the GABA type A receptor (GABAA-R) in the brain. Granule cells of the dentate gyrus (DGGCs) exhibit two components of inhibitory GABAergic transmission: a phasic component mediated by synaptic GABAA-Rs, and a tonic component mediated by extrasynaptic GABAA-Rs. Recordings of GABAergic currents were obtained from hippocampal slices prepared from rats in estrus, at pregnancy day 15 (P15) or P19, or at 2 d after delivery. Exogenous GABA or 3α,5α-THP induced an increase in tonic current in DGGCs that was significantly greater at P19 than in estrus. Neither tonic nor phasic currents were affected by pregnancy in CA1 pyramidal cells. Immunohistochemical analysis revealed a marked increase in the abundance of the δ subunit of the GABAA-R and a concomitant decrease in that of the γ2subunit in the hippocampus at P19. Expression of the α4subunit did not change during pregnancy but was increased 2 d after delivery. Treatment of rats from P12 to P18 with the 5α-reductase inhibitor finasteride prevented the changes in tonic current and in δ and γ2subunit expression normally apparent at P19. These data suggest that the number of extrasynaptic GABAA-Rs is increased in DGGCs during late pregnancy as a consequence of the associated marked fluctuations in the brain levels of neuroactive steroids.

20 January 2016 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
AFAlessandra Folci
Alessandra Folci
LMLuca Murru
Luca Murru
EVElena Vezzoli
Elena Vezzoli
LPLuisa Ponzoni
Luisa Ponzoni
LGLaura Gerosa
Laura Gerosa
SBSilvia Bassani
Silvia Bassani
Myosin IXa (Myo9a) is a motor protein that is highly expressed in the brain. However, the role of Myo9a in neurons remains unknown. Here, we investigated Myo9a function in hippocampal synapses. In rat hippocampal neurons, Myo9a localizes to the postsynaptic density (PSD) and binds the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) GluA2 subunit. Myo9a+/- mice displayed a thicker PSD and increased levels of PSD95 and surface AMPAR expression. Furthermore, synaptic transmission, long-term potentiation (LTP) and cognitive functions were impaired in Myo9a+/- mice. Together, these results support a key role for Myo9a in controlling the molecular structure and function of hippocampal synapses.

15 September 2005 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
PFPaolo Follesa
Paolo Follesa
FBFrancesca Biggio
Francesca Biggio
GTGiuseppe Talani
Giuseppe Talani
LMLuca Murru
Luca Murru
MSMariangela Serra
Mariangela Serra
GBGiovanni Biggio
Giovanni Biggio